Diagnostic News and Research

RSS

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

Today, the U.S. Food and Drug Administration permitted marketing of the PicoAMH Elisa diagnostic test as an aid in the determination of a patient's menopausal status.

25 Oct 2018

Researchers engineer new 'smart' repellent surface coatings

Researchers at McMaster University have solved a vexing problem by engineering surface coatings that can repel everything, such as bacteria, viruses and living cells, but can be modified to permit beneficial exceptions.

24 Oct 2018

NJIT team wins two major international awards for vision therapy platform

An NJIT-led team of engineers, game designers, artists and clinicians won two major international awards for its vision therapy platform, including "most innovative breakthrough," at the 2018 Augmented World Expo Europe, the leading industry conference for augmented reality technology.

24 Oct 2018

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

MWH Medical Pte Ltd, a leading homegrown medical group, and Siemens Healthineers are pleased to announce the launch of the first Asia Reference Center through their partnership.

From Siemens Healthineers 23 Oct 2018

Two Roche Diagnostic tests identified as transformative products for rapid uptake

Roche Diagnostics tests for suspected pre-eclampsia and heart attack have been recognized as ‘transformative’ and have been selected among only seven Rapid Uptake Products for the NHS.

From Roche Sequencing and Life Science 23 Oct 2018

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Scientists at the Center for Infection and Immunity in the Columbia University Mailman School of Public Health have developed the first diagnostic platform that can simultaneously screen for all known human pathogenic bacteria as well as markers for virulence and antibiotic resistance.

23 Oct 2018

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

An interview with Dr.

From Huron Technologies 23 Oct 2018

Construction is underway for second proton therapy system at Siteman Cancer Center

Mevion Medical System announces that construction is underway for a second proton therapy system at Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis. T

23 Oct 2018

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

As the number of Americans who regularly use cannabis has climbed, so too has the number of those experiencing cannabis withdrawal symptoms.

23 Oct 2018

New approach may lead to better diagnostic techniques for autoimmune disorders

If we really want to know how our body's cells work - or don't work, in the case of disease - we might need to look beyond their genes and even beyond the proteins they are made of.

23 Oct 2018

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia and a diagnostic test to determine which AML patients would most likely benefit from this treatment.

22 Oct 2018

Stratasys to showcase potential of 3D printed models at MEDICA 2018

This year’s MEDICA World Forum for Medicine (Düsseldorf, 12-15 November) will see Stratasys (Hall 9, Stand D12) demonstrate how medical institutions and their suppliers throughout the world are using advanced 3D printing across the entire value chain.

22 Oct 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

AstraZeneca and Merck & Co., Inc., Kenilworth, N.J., today announced detailed results from the Phase III SOLO-1 trial testing LYNPARZA (olaparib) 300 mg tablets twice-daily as a maintenance treatment for patients with newly diagnosed advanced BRCA-mutated ovarian cancer who were in complete or partial response following 1st-line standard platinum-based chemotherapy.

22 Oct 2018

Ultromics expands multiple clinical trials for coronary heart disease to the U.S.

Ultromics is currently supporting multiple ongoing clinical trials including “Rainier”, based in the U.S., and “EVAREST”, in the UK.

19 Oct 2018

AI pathology diagnostic tool developed using deep learning technology from Olympus

Since 2017, Olympus Corporation has participated in a joint research program that has the potential to help streamline the workload of clinical pathologists, called “A New Approach to Develop Computer-Aided Diagnosis Using Artificial Intelligence (AI) for Gastric Biopsy Specimens”.

From Evident Corporation - Life Sciences 18 Oct 2018

Simple, inexpensive test quickly detects antibiotic-resistant 'superbugs'

When you get sick, you want the right treatment fast. But certain infectious microbes are experts at evading the very anti-bacterial drugs designed to fight them.

16 Oct 2018

Research reveals how the inner ear processes speech

Results from a research study published in Nature Communications show how the inner ear processes speech, something that has until now been unknown. The authors of the report include researchers from Linköping University, Sweden, and Oregon Health & Science University, United States.

15 Oct 2018

NAM special publication outlines steps to ensure interoperability of health care systems

While health care has made great strides in recent years with the proliferation of electronic health records, establishment of regional health information exchanges, and development of data exchange standards and interfaces, interoperability among health care technologies remains very limited, says a new National Academy of Medicine special publication.

15 Oct 2018

Scientists demonstrate the existence of grid-like activity in the human brain

It has long been known that so-called place cells in the human hippocampus are responsible for coding one's position in space.

12 Oct 2018

Diagnosing Atrial Fibrillation in 30 Seconds

An interview with Glyn Barnes, Marketing Director for AliveCor, about Kardia Mobile and the Kardia Band, the FDA approved devices which can provide a diagnostic quality ECG reading in 30 seconds.

From AliveCor, Inc. 11 Oct 2018

Diagnostic News and Research

FDA authorizes marketing of PicoAMH Elisa test to help determine woman's menopausal status

Researchers engineer new 'smart' repellent surface coatings

NJIT team wins two major international awards for vision therapy platform

MWH Medical and Siemens Healthineers partner to launch first Asia Reference Center in Singapore

Two Roche Diagnostic tests identified as transformative products for rapid uptake

New diagnostic platform simultaneously screens for all known pathogenic bacteria

Patient Outcomes of Prostate Cancer with Whole Slide Imaging

Construction is underway for second proton therapy system at Siteman Cancer Center

Study: 12% of frequent marijuana smokers experience cannabis withdrawal syndrome

New approach may lead to better diagnostic techniques for autoimmune disorders

Researchers develop promising targeted strategy to treat chemo-resistant blood cancer

Stratasys to showcase potential of 3D printed models at MEDICA 2018

LYNPARZA Phase III SOLO-1 results show improved outcome for patients with advanced BRCA-mutated ovarian cancer

Ultromics expands multiple clinical trials for coronary heart disease to the U.S.

AI pathology diagnostic tool developed using deep learning technology from Olympus

Simple, inexpensive test quickly detects antibiotic-resistant 'superbugs'

Research reveals how the inner ear processes speech

NAM special publication outlines steps to ensure interoperability of health care systems

Scientists demonstrate the existence of grid-like activity in the human brain

Diagnosing Atrial Fibrillation in 30 Seconds

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News